Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
Clinical trial NCT01516424 · COMPLETED
Trial details
- NCT number
- NCT01516424
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-02-01
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.